Novel therapeutic potential of the PARP inhibitor talazoparib in synovial sarcoma and its combined effect with ATR inhibitor. - Honda N; Taniguchi H; Ono S; Hayashi F; Imamura E; Gyotoku H; Takemoto S; Takazono T; Ishimoto H; Sakamoto N; Obase Y; Masutani M; et al. (Discover oncology, 2026)